Cochlear (FRA:OC5) FFO


FRA:OC5 Cochlear Ltd FRA:OC5
75 GF Score
Price €70.64
GF Value €185.38
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Cochlear FFO?

FFO (Funds from operations) only applies to REITs.

FRA:OC5
75GF Score
Cochlear Ltd FRA:OC5
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cochlear (FRA:OC5) Overvalued in 2026?

Based on GuruFocus' analysis, Cochlear stock appears to be undervalued. The current stock price of €70.64 is trading 61.9% below its estimated GF Value™ of €185.38. GuruFocus considers Cochlear to be Significantly Undervalued.

Key valuation signals for FRA:OC5:

  • FFO:
  • GF Value™: €185.38 vs. price of €70.64 (61.9% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the FRA:OC5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cochlear Business Description

Address 1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.
75GF Score

Get the complete analysis for FRA:OC5

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€70.64
Price
€185.38
GF Value